Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03432416 · ClinicalTrials.gov registry record · Phase 2
Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring
A Phase 2 study, sponsored by Premier Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 385
- Enrollment target
NCT03432416 is a Phase 2 study that has completed, run by Premier Research. The registered enrollment target is 385 participants.
The verdict
NCT03432416, a Phase 2 study, has completed, sponsored by Premier Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 385 participants
- Enrollment target
Study Summary
This will be a multi-site, open-label, randomized clinical trial. The investigators will randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that are to be followed when using a contraceptive vaginal ring delivering a daily dose of Nestorone® and estradiol (NES-E2 CVR).
Interventions
- DRUG NES-E2 CVR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 385 participants |
| Start Date | 2018-02-12 |
| Est. Completion | 2021-12-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03432416
The ClinicalTrials.gov registry entry for NCT03432416 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Premier Research, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NES-E2 CVR is the first listed.
NCT03432416 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03432416 about?
NCT03432416 is a clinical study titled "Study of Efficacy, Cycle Control, and Safety of a NES-E2 Contraceptive Vaginal Ring". This will be a multi-site, open-label, randomized clinical trial. The investigators will randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that are to be followed when using a contraceptive vaginal ring delivering a daily dose of Nestorone® and estradiol (NES-E2 ...
What is the current status of trial NCT03432416?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 385 participants. The study started on 2018-02-12. Estimated completion is 2021-12-14.
What interventions are being tested in trial NCT03432416?
The interventions under investigation include: NES-E2 CVR (DRUG).
Who is sponsoring clinical trial NCT03432416?
This trial is sponsored by Premier Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.